Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease

Frontiers in Neurology

Volumn APR, Issue , 2012, Pages

  Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Biomarker; Cerebral amyloid angiopathy; Cerebrovascular disorders; Dementia; Intracerebral hemorrhage; Risk factor

Indexed keywords

EID: 84865849057     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00064     Document Type: Article

References (82)

1. Arima, H., Tzourio, C., Anderson, C., Woodward, M., Bousser, M. G., MacMahon, S., Neal, B., and Chalmers, J. (2010). Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the progress trial. Stroke 41, 394-396.
2. Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., and Schneider, J. A. (2011). Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann. Neurol. 69, 320-327.
3. Attems, J., Lauda, F., and Jellinger, K. A. (2008). Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J. Neurol. 255, 70-76.
4. Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augusti-nack, J. C, lohnson, K. A., Irizarry, M. C., Klunk, W. E., Mathis, C. A., Dekosky, S. T., Greenberg, S. M., Hyman, B. T., and Growdon, J. H. (2007). Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report. Arch. Neurol. 64, 431-434.
5. Bell, R. D., and Zlokovic, B. V. (2009). Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neu-ropathol. 118, 103-113.
6. Biffi, A., Shulman, J. M., Jagiella, J. M., Cortellini, L., Ayres, A. M., Schwab, K., Brown, D. L., Silliman, S. L., Selim, M., Worrall, B. B., Meschia, J. F., Slowik, A., De Jager, P. L., Greenberg, S. M., Schneider, J. A., Bennett, D. A., and Rosand, J. (2012). Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology 78, 334-341.
7. Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., Wilkinson, D., Holmes, C., and Nicoll, J. A. (2008). Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain. Brain 131, 3299-3310.
8. Brundel, M., de Bresser, J., van Dillen, J. J., Kappelle, L. J., and Biessels, G. J. (2012). Cerebral microinfarcts: a systematic review of neuropatho-logical studies. J. Cereb. Blood Flow Metab. 32, 425-436.
9. Carlson, C., Estergard, W., Oh, J., Suhy, J., Jack, C. R., Siemers, E., and Barakos, J. (2011). Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement. 7, 396-401.
10. Chen, Y. W., Gurol, M. E., Rosand, J., Viswanathan, A., Rakich, S. M., Groover, T. R., Greenberg, S. M., and Smith, E. E. (2006). Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 67, 83-87.
11. Christoforidis, M., Schober, R., and Krohn, K. (2005). Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. 31, 11-19.
12. Cordonnier, C., Al-Shahi Salman, R., and Wardlaw, J. (2007). Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130, 1988-2003.
13. Cordonnier, C., Leys, D., Dumont, E, Deramecourt, V., Bordet, R., Pasquier, F., and Hénon, H. (2010). What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Brain 133, 3281-3289.
14. Cordonnier, C and van der Flier, W. M. (2011). Brain microbleeds and Alzheimer's disease: innocentobservation or key player? Brain 134, 335-344.
15. Cordonnier, C., van der Flier, W M., Sluimer, J. D., Leys, D., Barkhof, F., and Scheltens, P. (2006). Prevalence and severity of microbleeds in a memory clinic setting. Neurology 66, 1356-1360.
16. Dierksen, G. A., Skehan, M. E., Khan, M. A., Jeng, J., Nandigam, R. N., Becker, J. A., Kumar, A., Neal, K. L., Betensky, R. A., Frosch, M. P., Rosand, J., Johnson, K. A., Viswanathan, A., Salat, D. H., and Greenberg, S. M. (2010). Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol. 68, 545-548.
17. Domingues-Montanari, S., Hernandez-Guillamon, M., Fernandez-Cadenas, I., Mendioroz, M., Boada, M., Munuera, J., Rovira, A., Maisterra, O., Pares, M., Gutierrez, M., Alvarez-Sabin, J., Chacon, P., Delgado, P., and Montaner, J. (2011). ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Neurobiol Aging 32, 9.
18. Eng, J. A., Frosch, M. P., Choi, K., Rebeck, G. W., and Greenberg, S. M. (2004). Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann. Neurol. 55, 250-256.
19. Feldman, H. H., Maia, L. F., Mackenzie, I. R., Forster, B. B., Martzke, J., andWoolfenden, A. (2008). Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 39, 2894-2897.
20. Goos, J. D., Kester, M. I., Barkhof, E, Klein, M., Blankenstein, M. A., Scheltens, P., and van der Flier, W. M. (2009). Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid bio-markers and cognition. Stroke 40, 3455-3460.
21. Greenberg, S. M., Gurol, M. E., Rosand, J., and Smith, E. E. (2004). Amyloid angiopathy-related vascular cognitive impairment. Stroke 35, 2616-2619.
22. Greenberg, S. M., Rebeck, G. W., Von-sattel, J. P., Gomez-Isla, T., and Hyman, B. T. (1995). Apolipopro-tein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38, 254-259.
23. Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bot-tiglieri, T., Rosand, J., Growdon, J. H., and Greenberg, S. M. (2006). Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66, 23-29.
24. Hamaguchi, T., Okino, S., Sodeyama, N., Itoh, Y., Takahashi, A., Otomo, E., Matsushita, M., Mizusawa, H., and Yamada, M. (2005). Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy. J. Neurol. Neurosurg. Psychiatr. 76, 696-699.
25. Hanyu, H., Tanaka, Y., Shimizu, S., Takasaki, M., and Abe, K. (2003). Cerebral microbleeds in Alzheimer's disease. J. Neurol. 250, 1496-1497.
26. Herzig, M. C., Winkler, D. T., Burg-ermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., Danner, S., Abramowski, D., Sturchler-Pierrat, C., Burki, K., van Duinen, S. G., Maat-Schieman, M. L., Staufenbiel, M., Mathews, P. M., and Jucker, M. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amy-loidosis. Nat. Neurosci. 7, 954-960.
27. Hirohata, M., Yoshita, M., Ishida, C., Ikeda, S. I., Tamaoka, A., Kuzuhara, S., Shoji, M., Ando, Y., Tokuda, T., and Yamada, M. (2010). Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Eur. J. Neurol. 17, 823-829.
28. Izenberg, A., Aviv, R. I., Demaerschalk, B. M., Dodick, D. W., Hopyan, J., Black, S. E., and Gladstone, D. J. (2009). Crescendo transient aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke 40, 3725-3729.
29. Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W E., Mathis, C. A., Price, J. C., Dekosky, S. T., Fischman, A. J., and Greenberg, S. M. (2007). Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann. Neurol. 62, 229-234.
30. Kimberly, W. T., Gilson, A., Rost, N. S., Rosand, J., Viswanathan, A., Smith, E. E., and Greenberg, S. M. (2009). Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72, 1230-1235.
31. Kinnecom, C., Lev, M. H., Wendell, L., Smith, E. E., Rosand, J., Frosch, M. P., and Greenberg, S. M. (2007). Course of cerebral amyloid angiopathy-related inflammation. Neurology 68, 1411-1416.
32. Knudsen, K. A., Rosand, J., Karluk, D., and Greenberg, S. M. (2001). Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56, 537-539.
33. Kumar, S., Goddeau, R. P. Jr., Selim, M. H., Thomas, A., Schlaug, G., Alhaz-zani, A., Searls, D. E., and Caplan, L. R. (2010). Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 74, 893-899.
34. Leclercq, P. D., Murray, L. S., Smith, C., Graham, D. I., Nicoll, J. A., and Gentleman, S. M. (2005). Cerebral amyloid angiopathy in traumatic brain injury: association with apolipopro-tein E genotype. J. Neurol. Neuro-surg. Psychiatr. 76, 229-233.
35. Ly, J. V., Donnan, G. A., Villemagne, V. L., Zavala, J. A., Ma, H., O'Keefe, G., Gong, S. J., Gunawan, R. M., Saunder, T., Ackerman, U., Tochon-Danguy H., Churilov, L., Phan, T. G., and Rowe, C. C. (2010). 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology 74, 487-493.
36. McCarron, M. O., and Nicoll, J. A. (2004). Cerebral amyloid angiopathy and thrombolysis-related intrac-erebral haemorrhage. Lancet Neurol. 3, 484-492.
37. Nakata-Kudo, Y., Mizuno, T., Yamada, K., Shiga, K., Yoshikawa, K., Mori, S., Nishimura, T., Nakajima, K., and Nakagawa, M. (2006). Microb-leeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr. Cogn. Disord. 22, 8-14.
38. Nandigam, R. N., Viswanathan, A., Delgado, P., Skehan, M. E., Smith, E. E., Rosand, J., Greenberg, S. M., and Dickerson, B. C. (2009). MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am. J. Neu-roradiol. 30, 338-343.
39. Nicoll, J. A., Burnett, C., Love, S., Graham, D. I., Dewar, D., Ironside, J. W., Stewart, J., and Vinters, H. V. (1997). High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 41, 716-721.
40. Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., and Weller, R. O. (2003). Neuropathol-ogy of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9, 448-452.
41. O'Donnell, H. C., Rosand, J., Knudsen, K. A., Furie, K. L., Segal, A. Z., Chiu, R. I., Ikeda, D. and Greenberg, S. M. (2000). Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N. Engl. J. Med. 342, 240-245.
42. Oh, U., Gupta, R., Krakauer, J. W., Khandji, A. G., Chin, S. S., and Elkind, M. S. (2004). Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62, 494-497.
43. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A., and Hock, C. (2003). Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization, Neurology. 61, 46-54
44. Peila, R., Yucesoy, B., White, L. R., Johnson, V., Kashon, M. L., Wu, K., Petro-vitch, H., Luster, M., and Launer, L. J. (2007). ATGF-beta1 polymorphism association with dementia and neu-ropathologies: the HAAS. Neurobiol. Aging 28, 1367-1373.
45. Pettersen, J. A., Sathiyamoorthy, G., Gao, F. Q., Szilagyi, G., Nadkarni, N. K., St George-Hyslop, P., Rogaeva, E., and Black, S. E. (2008). Microbleed topography, leukoaraiosis, and cog nition in probable Alzheimer dis ease from the Sunnybrook dementia study. Arch. Neurol. 65, 790-795.
46. Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufen-biel, M., Mathews, P. M., and Jucker, M. (2002). Cerebral hemorrhage after passive anti-Aβ immunother-apy. Science 298, 1379.
47. Prada, C. M., Garcia-Alloza, M., Beten-sky, R. A., Zhang-Nunes, S. X., Greenberg, S. M., Bacskai, B. J., and Frosch, M. P. (2007). Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J. Neurosci. 27, 1973-1980.
48. Prelli, F., Castano, E., Glenner, G. G., and Frangione, B. (1988). Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51, 648-651.
49. Premkumar, D. R., Cohen, D. L., Hedera, P., Friedland, R. P., and Kalaria, R. N. (1996). Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148, 2083-2095.
50. Racke, M. M., Boone, L. I., Hepburn, D. L., Parsadainian, M., Bryan, M. T., Ness, D. K., Piroozi, K. S., Jordan, W. H., Brown, D. D., Hoffman, W P., Holtzman, D. M., Bales, K. R., Gitter, B. D., May, P. C., Paul, S. M., and DeMattos, R. B. (2005). Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β. J. Neurosci. 25, 629-636.
51. Robbins, E. M., Betensky, R. A., Dom-nitz, S. B., Purcell, S. M., Garcia-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., and Bacskai, B. J. (2006). Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J. Neurosci. 26, 365-371
52. Ronald, J. A., Chen, Y., Bernas, L., Kit-zler, H. H., Rogers, K. A., Hegele, R. A., and Rutt, B. K. (2009). Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. Brain 132, 1346-1354.
53. Rosand, J., Hylek, E. M., O'Donnell, H. C., and Greenberg, S. M. (2000). Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55, 947-951.
54. Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., Mulnard, R., Barakos, J., Gregg, K. M., Liu, E., Lieberburg, I., Schenk, D., Black, R., and Grundman, M. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73, 2061-2070.
55. Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seu-bert, P., and Games, D. (2008). Immunotherapy reduces vascular amyloid-β in PDAPP mice. J. Neurosci. 28, 6787-6793.
56. Scolding, N. J., Joseph, F., Kirby, P. A., Mazanti, I., Gray, F., Mikol, J., Ellison, D., Hilton, D. A., Williams, T. L., MacKenzie, J. M., Xuereb, J. H., and Love, S. (2005). Aβ-related angi-itis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128, 500-515.
57. Shinkai, Y., Yoshimura, M., Ito, Y., Odaka, A., Suzuki, N., Yanagisawa, K., and Ihara, Y. (1995). Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann. Neurol. 38, 421-428.
58. Smith, E. E., Gurol, M. E., Eng, J. A., Engel, C. R., Nguyen, T. N., Rosand, J., and Greenberg, S. M. (2004). White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63, 1606-1612.
59. Suter, O. C., Sunthorn, T., Kraft-sik, R., Straubel, J., Darekar, P., Khalili, K., and Miklossy, J. (2002). Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33, 1986-1992.
60. Suzuki, N., Iwatsubo, T., Odaka, A., Ishibashi, Y., Kitada, C., and Ihara, Y. (1994). High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452-460.
61. Thal, D. R., Ghebremedhin, E., Rub, U., Yamaguchi, H., Del Tredici, K., and Braak, H. (2002). Two types of sporadic cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 61, 282-293.
62. Thal, D. R., Papassotiropoulos, A., Saido, T. C., Griffin, W. S., Mrak, R. E., Kolsch, H., Tredici, K. D., Attems, J., and Ghebremedhin, E. (2010). Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathol. 120, 169-183.
63. Thoonsen, H., Richard, E., Bentham, P., Gray, R., van Geloven, N., De Haan, R. J., Van Gool, W A., and Nederkoorn, P. J. (2010). Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern? Stroke 41, 2690-2692.
64. Trouillas, P. and von Kummer, R. (2006). Classification and pathogen-esis of cerebral, hemorrhages afterthrombolysis in ischemic stroke. Stroke 37, 556-561.
65. van Rooden, S., Maat-Schieman, M. L., Nabuurs, R. J., van der Weerd, L., van Duijn, S., van Duinen, S. G., Natte, R., van Buchem, M. A., and van der Grond, J. (2009). Cerebral amy-loidosis: postmortem detection with human 7. 0-T MR imaging system. Radiology 253, 788-796.
66. Verbeek, M. M., Kremer, B. P., Rikkert, M. O., Van Domburg, P. H., Skehan, M. E., and Greenberg, S. M. (2009). Cerebrospinal fluid amyloid β(40) is decreased in cerebral amyloid angiopathy. Ann. Neurol. 66, 245-249.
67. Vernooij, M. W., Haag, M. D., van der Lugt, A., Hofman, A., Krestin, G. P., Stricker, B. H., and Breteler, M. M. (2009a). Use of antithrom-botic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch. Neurol. 66, 714-720.
68. Vernooij, M. W., Ikram, M. A., Hofman, A., Krestin, G. P., Breteler, M. M., and van der Lugt, A. (2009b). Superficial siderosis in the general population. Neurology 73, 202-205.
69. Viswanathan, A., Patel, P., Rahman, R., Nandigam, R. N., Kinnecom, C., Bracoud, L., Rosand, J., Chabriat, H., Greenberg, S. M., and Smith, E. E. (2008). Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke 39, 1988-1992.
70. Wilcock, D. M., Jantzen, P. T., Li, Q., Morgan, D., and Gordon, M. N. (2007). Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and micro hemorrhage while both reduce parenchymal amyloid. Neuroscience 144, 950-960.
71. Wilcock, D. M., Rojiani, A., Rosen-thal, A., Subbarao, S., Freeman, M. J., Gordon, M. N., and Morgan, D. (2004). Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J. Neuroinflammation 1, 24.
72. Yamada, M. (2002). Risk factors for cerebral amyloid angiopathy in the elderly. Ann. N. Y. Acad. Sci. 977, 37-44.
73. Yamada, M. (2004). Cerebral amyloid angiopathy and gene polymorphisms. J. Neurol Sci. 226, 41-44.
74. Yamada, M., Itoh, Y., Suematsu, N., Otomo, E., and Matsushita, M. (1997a). Vascular variant of Alzheimer's disease characterized by severe-plaque-like β protein angiopathy. Dement. Geriatr. Cogn. Disord. 8, 163-168.
75. Yamada, M., Sodeyama, N., Itoh, Y., Suematsu, N., Otomo, E., Matsushita, M., and Mizusawa, H. (1997b). Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 28, 2219-2221.
76. Yamada, M., and Naiki, H. (2012). Cerebral amyloid angiopathy. Prog. Mol. Biol. Transl. Sci. 107, 41-78.
77. Yamada, M., Sodeyama, N., Itoh, Y., Suematsu, N., Otomo, E., Matsushita, M., and Mizusawa, H. (1998). Association of a1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann. Neurol. 44, 129-131.
78. Yamada, M., Sodeyama, N., Itoh, Y., Takahashi, A., Otomo, E., Matsushita, M., and Mizusawa, H. (2003). Association of neprilysin polymorphism with cerebral amyloid angiopathy. J. Neurol. Neurosurg. Psychiatr. 74, 749-751.
79. Yamada, M., Tsukagoshi, H., Otomo, E., and Hayakawa, M. (1987). Cerebral amyloid angiopathy in the aged. J. Neurol. 234, 371-376.
80. Yates, P. A., Sirisriro, R., Villemagne, V. L., Farquharson, S., Masters, C. L., Rowe, C. C., and Group, A. R. (2011). Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology 77, 48-54.
81. Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., and DeCarli, C. S. (2006). Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 67, 2192-2198.
82. Zhu, Y C, Chabriat, H., Godin, O., Dufouil, C., Rosand, J., Greenberg, S. M., Smith, E. E., Tzourio, C., and Viswanathan, A. (2012). Distribution of white matter hyper-intensity in cerebral hemorrhage and healthy aging. J. Neurol. 259, 530-536.